Kinetics of emergence of liver complications in hepatitis C virus infected patients and advanced fibrosis, with and without HIV-coinfection, after sustained virological response

Autor: Corma-Gómez A, Macías J, Téllez F, Morano L, Rivero A, Serrano M, Ríos MJ, Vera-Méndez FJ, Santos M, Real LM, Palacios R, Santos IL, Geijo P, Imaz A, Merino D, Galindo MJ, Reus-Bañuls S, López-Ruz MÁ, Galera C, Pineda JA, RIS-HEP13 and GEHEP 011 study groups

Publikováno v: AIDS
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

OBJECTIVE: There is scarce available evidence on the distribution over time of liver complications emergence in hepatitis C virus (HCV)-infected patients who achieve sustained virological response (SVR) with direct-acting antiviral (DAA)-based therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::459ed170f2de5883a2b99b56b962d116
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=8245

IL7RA rs6897932 Polymorphism is Associated with Better CD4 + T-Cell Recovery in HIV Infected Patients Starting Combination Antiretroviral Therapy

Autor: Resino S, Navarrete-Muñoz MA, Blanco J, Pacheco YM, Castro I, Berenguer J, Santos J, Vera-Méndez FJ, Górgolas M, Jiménez-Sousa MAÁ, Benito JM, Rallón N, CoRIS and the HIV Biobank integrated in the Spanish AIDS Research Network Projec

Publikováno v: Biomolecules
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Interleukin-7 receptor subunit alpha (IL7RA) rs6897932 polymorphism is related to CD4 + recovery after combination antiretroviral therapy (cART), but no studies so far have analyzed its potential impact in patients with very low CD4 + T-cells count.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::14512578b0ac176655effa924a46ad6d
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=10375

No impact of HIV coinfection on the mortality in patients with hepatitis C virus infection after sustained virological response.

Autor: Martín-Carmona J; Cinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universidad de Sevilla (US), Sevilla, Spain., Corma-Gómez A; Cinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Téllez F; Unit of Infectious Diseases, Hospital Universitario de Puerto Real, Faculty of Medicine, Universidad de Cádiz, Spain., Arenga-Barrios D; Infectious Diseases, Hospital Universitario de Puerto Real, Cádiz, Spain., Serrano-Fuentes M; Unit of Infectious Diseases, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., Morano L; Unit of Infectious Diseases, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain. Instituto de Investigación Sanitaria Galicia Sur (IISGS), Spain., Corona-Mata D; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Clinical Virology and Zoonoses Research Group, Unit of Infectious Diseases, Hospital Universitario Reina Sofía, Spain.; Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Spain.; Universidad de Córdoba (UCO), Córdoba, Spain., Navarrete Lorite MN; Unit of Infectious Diseases, Hospital Universitario Virgen Macarena, Sevilla, Spain., Vera-Méndez FJ; Section of Infectious Medicine/Service of Internal Medicine, Hospital General Universitario Santa Lucía, Cartagena, Spain., Alados JC; Unit of Clinical Microbiology, University Hospital Jerez, Cadiz, Spain., Palacios R; Unit of Infectious Diseases and Microbiology, Hospital Virgen de la Victoria, Málaga, Spain., de Los Santos I; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Unit of Internal Medicine and Infectious Diseases, Hospital La Princesa, Madrid, Spain., Geijo P; Unit of Internal Medicine, Hospital General Virgen de la Luz, Cuenca, Spain., Imaz A; Unit of Infectious Diseases, Hospital Universitario Bellvitge, Barcelona, Spain., Merino D; Unit of Infectious Diseases and Microbiology, Hospital Universitario Juan Ramón Jimenez, Huelva, Spain., Reus-Bañuls SJ; Hospital General Universitario de Alicante, Alicante, Spain., Galindo MJ; Internal Medicine, Hospital Clínico Universitario de Valencia, Valencia, Spain., López-Ruz MÁ; Infectious Disease Unit, Internal Medicine Service, Virgen de las Nieves University Hospital, Granada, Spain., Galera C; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Pineda JA; Cinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.; Universidad de Sevilla (US), Sevilla, Spain., Macías J; Cinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.; Instituto de Biomedicina de Sevilla (IBiS)/CSIC, Seville, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Universidad de Sevilla (US), Sevilla, Spain.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Sep 18. Date of Electronic Publication: 2024 Sep 18.

Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues.

Autor: Gonzalez-Serna A; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain., Corma-Gomez A; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain., Tellez F; UGC Enfermedades Infecciosas, Hospital Universitario de Puerto Real, Departamento de Medicina, Universidad de Cádiz, Cádiz, Spain., García-Martin S; UGC Unidad Gestión Clínica de Microbiología, Hospital Universitario de Puerto Real, Cádiz, Spain., Rivero-Juarez A; Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Instituto Maimonides de Investigación Biomedica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Córdoba, Spain., Frias M; Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Instituto Maimonides de Investigación Biomedica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), Córdoba, Spain., Vera-Méndez FJ; Hospital General Universitario Santa Lucía, Cartagena, Spain., De Los Santos I; Unit of Internal Medicine and Infectious Diseases, Hospital La Princesa, Madrid, Spain., Merino D; Unit of Infectious Diseases, Hospital Juan Ramón Jiménez, Huelva, Spain., Morano L; Unit of Infectious Pathology, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain., Imaz A; HIV and STI Unit, Department of Infectious Diseases, Hospital Universitario de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Galera C; HIV and STI Unit, Internal Medicine Department, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Serrano M; Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas, Gran Canaria, Spain., Macias J; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain., Pineda JA; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.

Publikováno v: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2021 Aug 12; Vol. 76 (9), pp. 2375-2379.

Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals.

Autor: Corma-Gómez A; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville,  Spain., Macías J; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville,  Spain., Téllez F; Unit of Infectious Diseases, Hospital Universitario de Puerto Real, Facultad de Medicina, Universidad de Cadiz, Spain., Freyre-Carrillo C; Unit of Microbiology, Hospital Universitario de Puerto Real, Facultad de Medicina, Universidad de Cadiz, Spain., Morano L; Unit of Infectious Pathology, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain., Rivero-Juárez A; Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Instituto Maimonides de Investigación Biomedica de Córdoba (IMIBIC), Universidad de Córdoba (UCO),  Spain., Ríos MJ; Unit of Infectious Diseases, Hospital Universitario Virgen Macarena, Sevilla, Spain., Alados JC; Unit of Clinical Microbiology, University Hospital Jerez, Cadiz, Spain., Vera-Méndez FJ; Section of Infectious Medicine/Service of Internal Medicine, Hospital General Universitario Santa Lucía, Cartagena, Spain., Merchante N; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville,  Spain., Palacios R; Unit of Infectious Diseases and Microbiology, Hospital Virgen de la Victoria, Málaga, Spain., Granados R; Unit of Infectious Diseases, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain., Merino D; Unit of Infectious Diseases, Hospitales Juan Ramón Jiménez e Infanta Elena, Huelva, Spain., De Los Santos I; Unit of Internal Medicine and Infectious Diseases, Hospital La Princesa, Madrid, Spain., Pineda JA; Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville,  Spain.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 03; Vol. 71 (9), pp. 2354-2362.